Opioid detox for Wellington — fentanyl-era protocols, buprenorphine done right.

RECO Island is 28 miles east of Wellington — 38 minutes via Southern Boulevard and I-95 — and runs a small-census, physician-led opioid detox followed by direct in-house transition to residential treatment on the same campus. For clients in Olympia, Aero Club, Palm Beach Polo, or Wellington View, the inland distance makes daily commuting through opioid withdrawal impractical, and the residential model provides the containment that fentanyl-era detox actually requires. Buprenorphine induction is COWS-guided, low-dose and micro-induction protocols are available for fentanyl-exposed patients, and naloxone education for the client and at least one family member is standard at discharge.

Wellington sits 28 miles west of RECO Island’s Delray Beach campus — roughly 38 minutes east by car via Southern Boulevard or Lake Worth Road. For families in Olympia, Versailles, Aero Club, Palm Beach Polo, or Wellington View, the inland distance makes daily commuting through opioid withdrawal impractical. Opioid detox at RECO Island is delivered on an inpatient basis with direct in-house transition to residential treatment on the same campus — no waitlists, no third-party handoffs, no discharge into a stranger’s aftercare.

Opioid withdrawal in the fentanyl era

Fentanyl and its analogs have restructured what opioid withdrawal looks like clinically. Compared with heroin or prescription oxycodone, fentanyl’s higher potency, shorter receptor half-life, and unpredictable adulterant profile — xylazine, nitazenes, benzodiazepine analogs — produce a withdrawal syndrome that emerges faster, escalates harder, and does not follow the timelines addiction medicine relied on for two decades. Patients who used fentanyl within the prior 72 hours frequently retain lipophilic drug in tissue stores, which extends the window during which a standard buprenorphine induction can precipitate severe withdrawal.

The pre-fentanyl playbook — wait for moderate withdrawal at 12 to 24 hours, dose 2 to 4 mg buprenorphine sublingual, titrate up on day one — remains valid for prescription opioid and heroin patients, but frequently fails for regular fentanyl users. RECO Island’s medical team treats fentanyl exposure as the default clinical scenario: extended monitoring, later induction thresholds, and readiness to shift to low-dose or micro-induction protocols when indicated.

Adulterant screening is part of the intake picture. Xylazine — an alpha-2 agonist with no opioid receptor activity and no reversal agent — is now common in the fentanyl supply and produces prolonged sedation, autonomic instability, and characteristic skin lesions that require independent management alongside opioid withdrawal itself.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale (COWS) is the standard instrument for timing opioid detox medication. Eleven symptom domains — resting pulse, sweating, restlessness, pupil size, bone and joint aches, rhinorrhea and lacrimation, GI upset, tremor, yawning, anxiety and irritability, and gooseflesh skin — are scored on ordinal scales and totaled. Scores of 5 to 12 indicate mild withdrawal, 13 to 24 moderate, 25 to 36 moderately severe, and above 36 severe. Traditional buprenorphine induction begins when COWS crosses roughly 11 to 13, indicating adequate mu-receptor availability for a partial agonist to bind without displacing full agonist and precipitating withdrawal.

Initial doses are 2 to 4 mg sublingual, with redosing every 60 to 90 minutes based on symptom response, targeting a day-one total of 8 to 16 mg. For fentanyl-exposed patients, low-dose induction — sometimes called the Bernese method or micro-induction — layers small buprenorphine doses (starting at 0.5 mg) alongside ongoing full-agonist use over five to seven days, allowing the partial agonist to occupy receptors gradually without provoking precipitated withdrawal.

Comfort medications supplement induction throughout the acute window: clonidine for autonomic hyperactivity, loperamide for diarrhea, ondansetron for nausea, hydroxyzine for anxiety and sleep, and cyclobenzaprine or methocarbamol for the muscle pain that dominates day two through four.

Buprenorphine, methadone, or naltrexone — the MAT decision

Three medications have Level A evidence for opioid use disorder maintenance, and the choice between them shapes long-term outcome as much as the detox itself. Buprenorphine — sublingual film or the extended-release monthly injection (Sublocade) — is a partial mu-agonist with a ceiling effect on respiratory depression, office-based prescribing, and the strongest evidence base for reducing overdose mortality. Methadone, a full mu-agonist dispensed through federally licensed opioid treatment programs, has decades of outcome data and remains appropriate for patients who have failed buprenorphine or who need the structural containment of daily dispensing.

Extended-release naltrexone (Vivitrol) is a monthly intramuscular opioid antagonist. It carries no diversion risk and no dependence liability, but it requires a full 7 to 10 day opioid-free interval before the first injection — an interval most patients cannot tolerate outside a structured residential setting. This is precisely where the RECO Island model has an advantage: the residential window makes naltrexone induction feasible for patients who would otherwise never reach the medication.

The MAT decision is made during the detox stay with the client, using prior treatment response, family and occupational constraints, comorbid psychiatric picture, and the six ASAM Criteria dimensions to guide the recommendation. Motivational interviewing (MI) is the frame for that conversation; the decision is documented in the treatment plan and revisited at residential intake.

Naloxone education and the safety net

Every RECO Island opioid detox client, and at least one family member, leaves the facility with intranasal naloxone in hand and trained on its use. The rationale is not optional programming: post-detox is the highest-risk window for overdose mortality across an opioid use disorder trajectory. Tolerance drops substantially during the abstinence interval, so any return-to-use event carries meaningfully elevated respiratory depression risk at doses that would previously have been routine.

Naloxone (Narcan) training covers rescue-breathing technique, the 2 to 3 minute redose interval, and the reality that fentanyl overdoses frequently require two or three doses to fully reverse. Families receive written material and a return demonstration. This is paired with continued MAT — the single intervention with the largest effect size on post-treatment overdose mortality — and harm-reduction counseling that treats a possible return-to-use event as a clinical event to plan for, not a moral failure to shame.

What to expect on admission from Wellington

Most Wellington clients arrive at RECO Island’s Delray Beach campus by car — 38 minutes east on Lake Worth Road or Southern Boulevard, then south on I-95. Admissions are direct: no emergency department stop, no third-party assessment center. On arrival, a psychiatric provider and nursing team complete history, physical, urine toxicology, ECG, and comprehensive metabolic and hepatic panels within the first two hours.

Baseline instruments include COWS on admission and every four hours thereafter, PHQ-9 for depression, GAD-7 for anxiety, and ASRS, YBOCS, or PCL-5 when adult ADHD, OCD, or PTSD are clinically suggested. Co-occurring stimulant, alcohol, or benzodiazepine use is common in the fentanyl-era caseload; CIWA-Ar is added for alcohol or benzodiazepine co-detox. The medical stay typically runs 5 to 10 days, followed by direct transition into residential treatment on the same campus without a discharge break.

Insurance and admissions

RECO Island works with most major commercial plans including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS, in-network or out-of-network depending on the specific product. Admissions verifies benefits before arrival, including inpatient detox authorization, residential day rate, and any deductible or coinsurance exposure. Most PPO plans authorize the medical detox stay on ASAM Criteria documentation across the six dimensions — acute withdrawal, biomedical, emotional/behavioral, readiness to change, relapse potential, and recovery environment.

For Wellington families weighing options, admissions produces a written estimate of member responsibility, coordinates directly with an employer’s EAP where relevant, and accepts calls twenty-four hours daily — including 2 a.m. — routed to a live clinician rather than a call center.

Serving residents of: Olympia, Versailles, Aero Club, Palm Beach Polo, Wellington View.